
    
      The primary study objective is to compare the efficacy of BBR 2778 to a selection of single
      agents. Secondary objectives are to compare the safety and tolerability of BBR 2778 to a
      selection of single agents, and to assess the pharmacokinetic parameters of BBR 2778 in a
      subset of this patient population.
    
  